School of Medicine
Showing 1-12 of 12 Results
-
Rebecca M. Gardner
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2022
BioMy research interests are around hyperemesis gravidarum (HG), defined as severe nausea and vomiting during pregnancy that often leads to significant maternal undernutrition, and is one of the primary causes of hospitalization during pregnancy. I am interested in the link between HG and offspring outcomes, both around birth and into childhood; trends in antiemetic prescriptions; and whether certain environmental exposures exacerbate HG symptoms, leading to hospitalization.
Before starting a PhD, I was a biostatistician in the Quantitative Sciences Unit at Stanford for four years where I co-authored over thirty publications, collaborating with clinicians on various domains including developmental behavioral pediatrics, reproductive endocrinology & infertility, oncology, and clinical trials. I completed my MS in Statistics at Brigham Young University in 2016, where I collaborated with cardiologists to develop a new approach to diagnose rheumatic heart disease in pediatric patients in Samoa for my Master's thesis. -
Pascal Geldsetzer
Assistant Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health
BioPascal Geldsetzer is an Assistant Professor of Medicine in the Division of Primary Care and Population Health and, by courtesy, in the Department of Epidemiology and Population Health. He is also affiliated with the Department of Biomedical Data Science, Department of Health Policy, King Center for Global Development, and the Stanford Centers for Population Health Sciences, Innovation in Global Health, and Artificial Intelligence in Medicine & Imaging.
His research focuses on identifying and evaluating the most effective interventions for improving health at older ages. In addition to leading several randomized trials, his methodological emphasis lies on the use of quasi-experimental approaches to ascertain causal effects in large observational datasets, particularly in electronic health record data. He has won an NIH New Innovator Award (in 2022), a Chan Zuckerberg Biohub investigatorship (in 2022), and two NIH R01 grants as Principal Investigator (both in 2023). -
Paul-Andre Genest
Adjunct Professor, Epidemiology and Population Health
BioDr. Paul-André Genest is an Assistant Director and Publisher at the American Chemical Society where he is responsible for the management of roughly a third of the ACS journals portfolio and Editorial Development team. Since 2016, he is an Adjunct Professor at Stanford University where he co-teaches a yearly course on scholarly communication (BIOS 292: Preparation and Practice: Scientific Communication & Media). Previously, he worked as a Publisher and Senior Editor at Wiley and as an Associate Publisher and Scientific Editor at Elsevier. Dr. Genest has a BSc (Biology) degree and a MSc (Microbiology-Immunology) degree from the Université Laval in Québec City, Canada, and a PhD (Molecular Parasitology) from the University of Amsterdam, The Netherlands. He held two postdoc research positions at the Netherlands Cancer Institute in Amsterdam, The Netherlands before transitioning to the scholarly publishing industry.
-
Ruth Margaret Gibson
Postdoctoral Scholar, Health Policy
Current Research and Scholarly InterestsPurpose: This project is dedicated to assessing the potential impact on civilians - particularly children - in vulnerable countries in the Indo-Pacific resulting from a variety of escalation scenarios. These scenarios include trade blockages, economic pressure through restricting trade or sanctions, scenarios of oil and food shortages, and war. This study brings together scholars from political science, military strategy, simulation modeling, and population health, to conduct research on the pr
-
Nicole Gladish
Research Fellow, Epidemiology and Population Health
BioDr. Nicole Gladish is a Research Fellow in the Department of Epidemiology and Population Health at Stanford University. Her work integrates genetic, epigenetic, and population-level data to understand how biological and environmental factors interact to shape health disparities and influence trajectories of healthy aging. In addition to exploring molecular mechanisms, she conducts applied research on health policy interventions developing and refining tools like deprivation indices to inform equitable decision-making at the systems level.
Dr. Gladish earned her Ph.D. in Medical Genetics from the University of British Columbia (UBC), where her thesis focused on how early-life adversity, such as low socioeconomic status and abuse, affects DNA methylation patterns. This work aimed to elucidate the biological mechanisms that predispose individuals to chronic diseases such as cardiovascular disease, diabetes, and cancer.
At Stanford, she continues to investigate the interplay between social determinants and biological risk, with a growing emphasis on translational research. Her development of improved social deprivation indices supports more accurate identification of disadvantaged communities, informing public health funding, service allocation, and structural interventions across the U.S.
Dr. Gladish's work bridges molecular epidemiology and public policy, aiming to ensure that scientific insights translate into measurable improvements in population health. -
Steven Goodman
Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy
Current Research and Scholarly InterestsI study issues relating to the representation and measurement of evidence in medical research and determinants of the reliability of biomedical research findings. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research.
